ERP29 and lung carcinoma: In contrast, ERP29 downexpression was associated with decreased RT resistance in nasopharyngeal carcinoma cells19,20, increased CDDP efficacy in lung cancer cell line with null p5317, and better prognosis of colorectal cancer patients13.